Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

NCT06084780 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Secondary Malignant Neoplasm of Retroperitoneum
Secondary Malignant Neoplasm of Peritoneum
Pseudomyxoma Peritonei

Interventions

PROCEDURE: Intestinal, Multivisceral or Modified Multivisceral Transplantation
DRUG: Alemtuzumab
DRUG: Tacrolimus
DRUG: Sirolimus

Sponsor

Case Comprehensive Cancer Center